Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Zilver PTX Drug-Eluting Peripheral Stent Reveals Positive Data
The prospective, single-arm study is ongoing to evaluate the drug-eluting stent for the treatment of peripheral artery disease (PAD). Results of a separate pivotal randomized study in a
The prospective, single-arm study is ongoing to evaluate the drug-eluting stent for the treatment of peripheral artery disease (PAD). Results of a separate pivotal randomized study in a
Under the supply agreement, SkyPeople is expected to supply Boai with 150metric tons of Turnjujube concentrate valued at approximately $2.2m in aggregate for use in the production of
Bayer HealthCare Pharmaceuticals claimed that Natazia is the first and only oral contraceptive that contains an estrogen called estradiol valerate and a progestin called dienogest. Estradiol valerate is
Located in South Florida (USA), the new facility is expected to offer final assembly, labeling and packaging services to SHL’s pharmaceutical and biotech customers. SHL has been expanding
Namenda is a NMDA-receptor antagonist. It works by blocking excess activity of a substance in the brain called glutamate, which may reduce the symptoms associated with Alzheimer disease.
Dynavax Technologies said that this starts a 12-month follow-up on these subjects and sets the study’s completion for May 2011. The event supports its goal of a BLA
The increase results from the recognition as revenues during the first quarter of 2010 of EUR7.42m corresponding to the initial license payment received from Bausch + Lomb following
Silodyx is a new compound indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) and recently approved by the European Medicines Agency (EMA).
Bayer said that Regorafenib is a potent oral multi-kinase inhibitor with a kinase inhibition profile targeting angiogenic, stromal and oncogenic receptor tyrosine kinases. The Correct (Patients with metastatic
The US Patent No 7,704,977, ‘Solid Oral Dosage Form Containing an Enhancer’ covers Orazol tablets, an oral form of zoledronic acid, a bisphosphonate. The expiry date on this